Genetic products which are differentially expressed in tumors and use thereof | Patent Number 08765389

US 08765389 B2
Application Number10570957
Publication NumberUS 20100203040 A1
Pendency9 years, 9 months, 26 days
Filled DateSep 10, 2004
Priority DateSep 10, 2004
Publication DateAug 12, 2010
Expiration DateSep 10, 2024
Inventor/ApplicantsMichael Koslowski
Öezlem Tüereci
Oezlem Tuereci
Ugur Sahin
ExaminesXIAO, YAN
Art Unit1642
Technology Center1600
Assignments
Biontech Ag
Current
Ganymed Pharmaceuticals AgAstellas Pharma Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.